tetano
Editor, Senior Moderator
J Stroke Cerebrovasc Dis
. 2021 Oct 5;30(12):106152.
doi: 10.1016/j.jstrokecerebrovasdis.2021.106152. Online ahead of print.
Successful Endovascular Therapy in COVID-19 Associated Pediatric Ischemic Stroke
Dinesh V Jillella[SUP] 1 [/SUP], Bryan Philbrook[SUP] 2 [/SUP], Elissa Ortolani[SUP] 3 [/SUP], Jonathan A Grossberg[SUP] 4 [/SUP], Tristan Stani[SUP] 5 [/SUP], Owen Samuels[SUP] 6 [/SUP], Cederic Pimentel[SUP] 7 [/SUP], Amy Harrison[SUP] 8 [/SUP], Ashok R Polu[SUP] 9 [/SUP], Benjamin I Siegel[SUP] 10 [/SUP], Ian McCullough[SUP] 11 [/SUP], Michael Cawley[SUP] 12 [/SUP], Fadi Nahab[SUP] 13 [/SUP]
Affiliations
Abstract
Cerebrovascular diseases attributed to coronavirus disease 2019 (COVID-19) are uncommon but can result in devastating outcomes. Pediatric acute ischemic strokes are themselves rare and with very few large vessel occlusion related acute ischemic strokes attributed to COVID-19 described in the literature as of date. COVID-19 pandemic has contributed to acute stroke care delays across the world and with pediatric endovascular therapy still in its infancy, it poses a great challenge in facilitating good outcomes in children presenting with acute ischemic strokes in the setting of COVID-19. We present a pediatric patient who underwent endovascular therapy for an internal carotid artery occlusion related acute ischemic stroke in the setting of active COVID-19 and had an excellent outcome thanks to a streamlined stroke pathway involving the vascular neurology, neuro-interventional, neurocritical care, and anesthesiology teams.
Keywords: COVID-19; COVID-19 in children; Endovascular therapy; Hypercoagulable state; Pediatric stroke; Stroke in children; Stroke therapy.
. 2021 Oct 5;30(12):106152.
doi: 10.1016/j.jstrokecerebrovasdis.2021.106152. Online ahead of print.
Successful Endovascular Therapy in COVID-19 Associated Pediatric Ischemic Stroke
Dinesh V Jillella[SUP] 1 [/SUP], Bryan Philbrook[SUP] 2 [/SUP], Elissa Ortolani[SUP] 3 [/SUP], Jonathan A Grossberg[SUP] 4 [/SUP], Tristan Stani[SUP] 5 [/SUP], Owen Samuels[SUP] 6 [/SUP], Cederic Pimentel[SUP] 7 [/SUP], Amy Harrison[SUP] 8 [/SUP], Ashok R Polu[SUP] 9 [/SUP], Benjamin I Siegel[SUP] 10 [/SUP], Ian McCullough[SUP] 11 [/SUP], Michael Cawley[SUP] 12 [/SUP], Fadi Nahab[SUP] 13 [/SUP]
Affiliations
- PMID: 34649038
- DOI: 10.1016/j.jstrokecerebrovasdis.2021.106152
Abstract
Cerebrovascular diseases attributed to coronavirus disease 2019 (COVID-19) are uncommon but can result in devastating outcomes. Pediatric acute ischemic strokes are themselves rare and with very few large vessel occlusion related acute ischemic strokes attributed to COVID-19 described in the literature as of date. COVID-19 pandemic has contributed to acute stroke care delays across the world and with pediatric endovascular therapy still in its infancy, it poses a great challenge in facilitating good outcomes in children presenting with acute ischemic strokes in the setting of COVID-19. We present a pediatric patient who underwent endovascular therapy for an internal carotid artery occlusion related acute ischemic stroke in the setting of active COVID-19 and had an excellent outcome thanks to a streamlined stroke pathway involving the vascular neurology, neuro-interventional, neurocritical care, and anesthesiology teams.
Keywords: COVID-19; COVID-19 in children; Endovascular therapy; Hypercoagulable state; Pediatric stroke; Stroke in children; Stroke therapy.